$FHLD
Freedom Holdings, Inc.

2023 Q1 Form 10-Q Financial Statement

#000147793223003769 Filed on May 19, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.357K $3.266K
YoY Change -27.83% 809.75%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $28.55K $65.01K
YoY Change -56.09% 18009.47%
Operating Profit -$28.55K -$65.01K
YoY Change -56.09% 18009.47%
Interest Expense $2.946K $6.005K
YoY Change -50.94% 164.19%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$31.49K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$31.49K -$311.7M
YoY Change -99.99% 11844267.29%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 9.309M shares 328.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.390K
YoY Change
Cash & Equivalents $7.386K $489.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.386K $489.00
YoY Change 1410.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.386K $489.00
Total Long-Term Assets $0.00 $0.00
Total Assets $7.386K $489.00
YoY Change 1410.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.69K $68.93K
YoY Change -14.85%
Accrued Expenses $242.2K $245.0K
YoY Change -1.12%
Deferred Revenue
YoY Change
Short-Term Debt $35.86K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $337.7K $337.8K
YoY Change -0.03%
LONG-TERM LIABILITIES
Long-Term Debt $88.85K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $88.85K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $337.7K $337.8K
Total Long-Term Liabilities $88.85K
Total Liabilities $426.6K $432.6K
YoY Change -1.4%
SHAREHOLDERS EQUITY
Retained Earnings -$9.815M -$321.5M
YoY Change -96.95%
Common Stock $4.931K $32.87K
YoY Change -85.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$419.2K -$432.1K
YoY Change
Total Liabilities & Shareholders Equity $7.386K $489.00
YoY Change 1410.43%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$31.49K -$311.7M
YoY Change -99.99% 11844267.29%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$17.39K -$311.7M
YoY Change -99.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.63K $311.7M
YoY Change -99.99%
NET CHANGE
Cash From Operating Activities -17.39K -$311.7M
Cash From Investing Activities
Cash From Financing Activities 24.63K $311.7M
Net Change In Cash 7.240K -$1.643K
YoY Change -540.66%
FREE CASH FLOW
Cash From Operating Activities -$17.39K -$311.7M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7386 usd
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9308825 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9308825 shares
us-gaap Net Income Loss
NetIncomeLoss
-36693 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
88845 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
92203 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
940 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
574 usd
CY2023Q1 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
89785 usd
CY2022Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
92777 usd
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001386044
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Entity File Number
EntityFileNumber
000-54853
dei Entity Registrant Name
EntityRegistrantName
FREEDOM HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
dei Entity Address Address Line1
EntityAddressAddressLine1
10524 Independence Ave.
dei Entity Address City Or Town
EntityAddressCityOrTown
Chatsworth
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91311
dei City Area Code
CityAreaCode
813
dei Local Phone Number
LocalPhoneNumber
699-4098
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9308825 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
177 usd
CY2022Q3 us-gaap Assets
Assets
177 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
44687 usd
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
574 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243654 usd
CY2023Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
35855 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
31530 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
337705 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
320445 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
88845 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
92203 usd
CY2023Q1 us-gaap Liabilities
Liabilities
426550 usd
CY2022Q3 us-gaap Liabilities
Liabilities
412648 usd
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
4931 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
931 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9410428 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9364428 usd
CY2023Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
20000 usd
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9814523 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9777830 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-419164 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7386 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
26191 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
61747 usd
us-gaap Professional Fees
ProfessionalFees
28048 usd
us-gaap Professional Fees
ProfessionalFees
68870 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2357 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3266 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2635 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3844 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
28548 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
65013 usd
us-gaap Operating Expenses
OperatingExpenses
30683 usd
us-gaap Operating Expenses
OperatingExpenses
72714 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28548 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-65013 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-30683 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-72714 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
311672729 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
311672729 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2946 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
6005 usd
us-gaap Interest Expense
InterestExpense
6010 usd
us-gaap Interest Expense
InterestExpense
9600 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-31494 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-311743747 usd
us-gaap Net Income Loss
NetIncomeLoss
-36693 usd
us-gaap Net Income Loss
NetIncomeLoss
-311755043 usd
CY2023Q1 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
CY2022Q1 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.95
fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-1.89
CY2023Q1 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
34197714 shares
CY2022Q1 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
328672791 shares
fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
21616517 shares
fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
164875954 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2022 fhld Conversion Of Preferred Shares Into Common Amount
ConversionOfPreferredSharesIntoCommonAmount
0 usd
CY2022 fhld Cancellation Of Common Stock Amount
CancellationOfCommonStockAmount
-980 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-61698 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
fhld Stock Issued During Period Acquisitions Amount
StockIssuedDuringPeriodAcquisitionsAmount
30000 usd
us-gaap Net Income Loss
NetIncomeLoss
-36693 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-419164 usd
us-gaap Profit Loss
ProfitLoss
36693 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
311755043 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
12569 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
59835 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
366 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-561 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23758 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-311695769 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-3358 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-2133 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
4325 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
23530 usd
fhld Issuance Of Stock For Related Party Acquisition
IssuanceOfStockForRelatedPartyAcquisition
30000 usd
CY2022Q1 fhld Issuance Of Stock For Related Party Acquisition
IssuanceOfStockForRelatedPartyAcquisition
311672729 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30967 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311694126 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7209 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1643 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2132 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7386 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489 usd
us-gaap Interest Paid Net
InterestPaidNet
6010 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
6005 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. </p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
242222 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243654 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9814523 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2021Q4 fhld Preferred Stock Description
PreferredStockDescription
On December 30, 2021, the Company converted all of the 710,676 shares of issued and outstanding preferred stock consisting of Series A, B, C and D preferred stock, into 15,920,945 shares of common stock.
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
40000000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00125
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000000 usd
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49308825 shares

Files In Submission

Name View Source Status
0001477932-23-003769-index-headers.html Edgar Link pending
0001477932-23-003769-index.html Edgar Link pending
0001477932-23-003769.txt Edgar Link pending
0001477932-23-003769-xbrl.zip Edgar Link pending
fhld-20230331.xsd Edgar Link pending
fhld_10q.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex312.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
fhld_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
fhld-20230331_pre.xml Edgar Link unprocessable
fhld-20230331_cal.xml Edgar Link unprocessable
fhld-20230331_lab.xml Edgar Link unprocessable
fhld-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fhld_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending